Literature DB >> 11233756

Neuron-astrocyte interactions: implications for cellular energetics and antioxidant levels.

M Aschner1.   

Abstract

The interaction between astrocytes and neurons is examined from the standpoint of glutamate and glutathione (GSH) metabolism. These examples are outlined to provoke a reformulation of concepts of the inter-dependence between these 2 cell types, not only in terminating excitotoxicity, but also in assuring proper energetics and neuromodulation by astrocytic removal of glutamate via the astrocyte-specific glutamate transporters, GLT1 and GLAST. In addition, the role of astrocytes in the synthesis of neuronal GSH is detailed. The neuron-astrocyte interaction permits widely divergent aspects of brain energetics and modulation, and undoubtedly brain pathology where the functional unit is altered. Testing the developmental effects of compounds on this interaction is warranted and likely to establish the mechanisms by which it is compromised in a variety of disease states.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11233756

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  13 in total

1.  Supportive or information-processing functions of the mature protoplasmic astrocyte in the mammalian CNS? A critical appraisal.

Authors:  Harold K Kimelberg
Journal:  Neuron Glia Biol       Date:  2007-08

2.  Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on.

Authors:  Antonio Gonzalez
Journal:  Neurochem Res       Date:  2020-01-27       Impact factor: 3.996

3.  Manganese-induced oxidative DNA damage in neuronal SH-SY5Y cells: attenuation of thymine base lesions by glutathione and N-acetylcysteine.

Authors:  Adrienne P Stephenson; Jeffrey A Schneider; Bryant C Nelson; Donald H Atha; Ashok Jain; Karam F A Soliman; Michael Aschner; Elizabeth Mazzio; R Renee Reams
Journal:  Toxicol Lett       Date:  2013-01-04       Impact factor: 4.372

4.  Morphological alterations and cell death provoked by the branched-chain alpha-amino acids accumulating in maple syrup urine disease in astrocytes from rat cerebral cortex.

Authors:  Cláudia Funchal; Carmem Gottfried; Lúcia Maria Vieira de Almeida; André Quincozes dos Santos; Moacir Wajner; Regina Pessoa-Pureur
Journal:  Cell Mol Neurobiol       Date:  2005-08       Impact factor: 5.046

Review 5.  Functions of astrocytes and their potential as therapeutic targets.

Authors:  Harold K Kimelberg; Maiken Nedergaard
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

6.  Consumption of redox energy by glutathione metabolism contributes to hypoxia/ reoxygenation-induced injury in astrocytes.

Authors:  Petr Makarov; Siegfried Kropf; Ingrid Wiswedel; Wolfgang Augustin; Lorenz Schild
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

7.  Novel role of the nociceptin system as a regulator of glutamate transporter expression in developing astrocytes.

Authors:  Logan C Meyer; Caitlin E Paisley; Esraa Mohamed; John W Bigbee; Tomasz Kordula; Hope Richard; Kabirullah Lutfy; Carmen Sato-Bigbee
Journal:  Glia       Date:  2017-09-14       Impact factor: 7.452

8.  Chronic inflammation alters production and release of glutathione and related thiols in human U373 astroglial cells.

Authors:  Megan L Steele; Stacey Fuller; Annette E Maczurek; Cindy Kersaitis; Lezanne Ooi; Gerald Münch
Journal:  Cell Mol Neurobiol       Date:  2012-07-31       Impact factor: 5.046

9.  Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult.

Authors:  Andrew D Kraft; Delinda A Johnson; Jeffrey A Johnson
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

10.  Regional susceptibility to domoic acid in primary astrocyte cells cultured from the brain stem and hippocampus.

Authors:  Santokh S Gill; Yangxun Hou; Talat Ghane; Olga M Pulido
Journal:  Mar Drugs       Date:  2008-02-14       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.